Smith & Nephew plc (NYSE:SNN – Get Rating) has received an average recommendation of “Buy” from the eight ratings firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among […]
Smith & Nephew (NYSE:SNN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, Zacks.com reports. According to Zacks, “Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, […]
Smith & Nephew plc (NYSE:SNN – Get Rating) has earned a consensus rating of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the […]
Smith & Nephew (NYSE:SNN – Get Rating) and Vicarious Surgical (NYSE:RBOT – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk. Analyst Recommendations This is a summary of recent recommendations […]
Smith & Nephew plc (LON:SN – Get Rating) declared a dividend on Tuesday, February 22nd, Upcoming.Co.Uk reports. Stockholders of record on Thursday, March 31st will be given a dividend of $0.23 per share on Wednesday, May 11th. This represents a dividend yield of 1.44%. The ex-dividend date of this dividend is Thursday, March 31st. This […]